Search research articles
Contact Us
Filters
Showing results (1-10 of 558) with videos related to
Page
of 56
Sort By:
Current Pharmaceutical Design
|
June 13, 2009
Designed multiple ligands: an emerging anti-HIV drug discovery paradigm
Peng Zhan, Xinyong Liu
Expert Opinion on Therapeutic Patents
|
April 5, 2011
Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 - 2010)
Peng Zhan, Xinyong Liu
Frontiers in Public Health
|
November 21, 2022
The impact of agricultural disasters on child development in rural China
Sipei Xu, Peng Zhan
Current Pharmaceutical Design
|
July 18, 2013
Heterocycle-thioacetic acid motif: a privileged molecular scaffold with potent, broad-ranging pharmacological activities
Yu'ning Song, Peng Zhan, Xinyong Liu
Science Bulletin
|
January 20, 2023
Reducing energy barriers of chemical reactions with a nanomicrocell catalyst consisting of integrated active sites in conductive matrices
Guo-Peng Zhan, Chuan-De Wu
International Journal of Genomics
|
October 1, 2025
NRG-1 Promotes Axon Regeneration of Dorsal Root Ganglion Neurons in Diabetic Rats via ITGB1/FAK/AKT Pathway
Peng Zhan, Hewei Xiong, Hongmei Zheng
Mini Reviews in Medicinal Chemistry
|
April 23, 2010
Naturally occurring and synthetic bioactive molecules as novel non-nucleoside HBV inhibitors
Peng Zhan, Xuemei Jiang, Xinyong Liu
Mini Reviews in Medicinal Chemistry
|
June 15, 2010
Cosalane and its analogues: a unique class of anti-HIV agents
Peng Zhan, Zhenyu Li, Xinyong Liu
Current Medicinal Chemistry
|
August 20, 2009
Recent advances in the discovery and development of novel HIV-1 NNRTI platforms: 2006-2008 update
Peng Zhan, Xinyong Liu, Zhenyu Li
Journal of Medicinal Chemistry
|
March 28, 2019
Resurrecting the Condemned: Identification of N-Benzoxaborole Benzofuran GSK8175 as a Clinical Candidate with Reduced Metabolic Liability
Peng Zhan, Dongwei Kang, Xinyong Liu
Page
of 56
Search research articles
Search
Showing results (1-10 of 558) with videos related to
Sort By:
Page
of 56
Current Pharmaceutical Design
|
June 13, 2009
Designed multiple ligands: an emerging anti-HIV drug discovery paradigm
Peng Zhan, Xinyong Liu
Expert Opinion on Therapeutic Patents
|
April 5, 2011
Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 - 2010)
Peng Zhan, Xinyong Liu
Frontiers in Public Health
|
November 21, 2022
The impact of agricultural disasters on child development in rural China
Sipei Xu, Peng Zhan
Current Pharmaceutical Design
|
July 18, 2013
Heterocycle-thioacetic acid motif: a privileged molecular scaffold with potent, broad-ranging pharmacological activities
Yu'ning Song, Peng Zhan, Xinyong Liu
Science Bulletin
|
January 20, 2023
Reducing energy barriers of chemical reactions with a nanomicrocell catalyst consisting of integrated active sites in conductive matrices
Guo-Peng Zhan, Chuan-De Wu
International Journal of Genomics
|
October 1, 2025
NRG-1 Promotes Axon Regeneration of Dorsal Root Ganglion Neurons in Diabetic Rats via ITGB1/FAK/AKT Pathway
Peng Zhan, Hewei Xiong, Hongmei Zheng
Mini Reviews in Medicinal Chemistry
|
April 23, 2010
Naturally occurring and synthetic bioactive molecules as novel non-nucleoside HBV inhibitors
Peng Zhan, Xuemei Jiang, Xinyong Liu
Mini Reviews in Medicinal Chemistry
|
June 15, 2010
Cosalane and its analogues: a unique class of anti-HIV agents
Peng Zhan, Zhenyu Li, Xinyong Liu
Current Medicinal Chemistry
|
August 20, 2009
Recent advances in the discovery and development of novel HIV-1 NNRTI platforms: 2006-2008 update
Peng Zhan, Xinyong Liu, Zhenyu Li
Journal of Medicinal Chemistry
|
March 28, 2019
Resurrecting the Condemned: Identification of N-Benzoxaborole Benzofuran GSK8175 as a Clinical Candidate with Reduced Metabolic Liability
Peng Zhan, Dongwei Kang, Xinyong Liu
Page
of 56